23andMe Investor Day Presentation Deck

23ME-00610 (P006): A Novel Immuno-oncology Antibody Targeting CD200R1 Jennifer Low, M.D., PhD Head of Therapeutics Development, and Adrian Jubb, M.B., Ch.B., Ph.D. Senior Clinical Development Fellow Copyright © 2022 23andMe, Inc. 23andMe 33

View entire presentation